Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Varex ImagingVREX -0.56%69 Receivables Turnover is 1.47 as of Mar. 2026. GuruFocus rates VREX with a GF Score™ of 69/100 and a GF Value™ of $14.01 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 811 Medical Devices & Instruments companies, Varex Imaging ranks better than 54.13% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Varex Imaging's Revenue for the
three
months ended in Mar. 2026 was $216.0 Mil. Varex Imaging's average Accounts Receivable for the
three
months ended in Mar. 2026 was $147.3 Mil.
Hence, Varex Imaging's Receivables Turnover for the
three
months ended in Mar. 2026 was 1.47.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Varex Imaging Receivables Turnover Related Terms
Varex Imaging Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Varex Imaging's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VREX vs VMD, DCTH, OFIX: Receivables Turnover Comparison
For the Medical Devices subindustry, Varex Imaging's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Varex Imaging Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Varex Imaging's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Varex Imaging's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Varex Imaging (VREX) has a Receivables Turnover of 1.47 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Varex Imaging and its competitors. According to the industry distribution chart, Varex Imaging ranks #372 out of 811 companies in the Medical Devices & Instruments industry, placing it in the top 45.9%.
Is Varex Imaging's Receivables Turnover too high?
Varex Imaging's current Receivables Turnover is 1.47. The Medical Devices & Instruments industry median Receivables Turnover is 5.51. Varex Imaging's value of 1.47 is 73.3% below this industry median. Based on the distribution chart, Varex Imaging ranks #372 out of 811 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Varex Imaging has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Varex Imaging's Receivables Turnover compare to VMD and DCTH?
According to the Medical Devices & Instruments industry distribution chart, Varex Imaging ranks #372 out of 811 companies for Receivables Turnover. This puts Varex Imaging in the upper half of its industry. The industry median Receivables Turnover is 5.51. Varex Imaging's value of 1.47 is 73.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.51, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Varex Imaging's current Receivables Turnover of 1.47 is 73.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Varex Imaging and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Varex Imaging's current Receivables Turnover is 1.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Varex Imaging stock overvalued right now?
Based on GuruFocus' analysis, Varex Imaging (VREX) is currently considered Modestly Undervalued. The stock's GF Value™ is $14.01, compared to a current price of $10.67 — trading 23.8% below its estimated fair value. The current Receivables Turnover is 1.47 and 73.3% below the Medical Devices & Instruments industry median of 5.51. Varex Imaging's overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Varex Imaging (VREX), the current Receivables Turnover is 1.47 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Varex Imaging (VREX) Overvalued in 2026?
Based on GuruFocus' analysis, Varex Imaging stock appears to be undervalued.
The current stock price of $10.67 is trading 23.8% below its estimated GF Value™ of $14.01.
GuruFocus considers Varex Imaging to be Modestly Undervalued.
Key valuation signals for VREX:
Receivables Turnover: 1.47
GF Value™: $14.01 vs. price of $10.67 (23.8% below fair value)
Industry Position: 73.3% below the Medical Devices & Instruments median (#372 of 811)
No single metric tells the full story. See the VREX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.
69GF Score
Get the complete analysis for VREX
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VREX has been successfully added to your 
